Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Urinary Tract Infection, January 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 88 articles: HTML format

Single Articles

1. SALIH TS, Al-Rrassam ZT, Muhammad MA, Ziwar HR, et al
   Genome sequence data of multidrug-resistant Enterococcus faecalis HMTZ24 carrying multiple virulence factors, isolated from a urinary tract infection in Mosul, Iraq.
   Data Brief. 2025;64:112352.
   Abstract
   
   
2. PANDEY S, Aravaanan ASK, Bhaskar E, Silambanan S, et al
   Biomarkers innovation in urinary tract infections: Insights into pathophysiology, antibiotic resistance, and clinical applications.
   World J Nephrol. 2025;14:110749.
   Abstract
   
   
3. MAY SS, Veillette JJ, Butler AM, Olson J, et al
   Effect of oral beta-lactam dosing on outcomes of bacteremic Gram-negative urinary tract infections: a real-world analysis.
   Microbiol Spectr. 2025 Dec 31:e0170425. doi: 10.1128/spectrum.01704.
   Abstract
   
   
4. WAWRYSIUK SP, Bogusiewicz M, Pachcinski O, Grywalska E, et al
   Fosfomycin susceptibility of uropathogens resistant to antibiotics used in peri-operative prophylaxis of urinary tract infection among patients after urogynaecological surgery.
   Ann Agric Environ Med. 2025;32:488-491.
   Abstract
   
   
5. MIR SS, Ali E, Alghamdi SAA, Alghamdi NM, et al
   Antimicrobial Resistance in Urinary Tract Infections Among Patients with and Without Renal Comorbidities: A Retrospective Study from Al-Baha, Saudi Arabia.
   Pathogens. 2025;14:1297.
   Abstract
   
   
6. KHALID F, Aljohani WJ, Akram A, Bukhari A, et al
   Epidemiology and Antimicrobial Resistance of Uropathogens in a Tertiary Care Center in Riyadh, Saudi Arabia: A One-Year Retrospective Analysis.
   Pathogens. 2025;14:1254.
   Abstract
   
   
7. TODI S, Soman R, Mehta Y, Ramasubramanian V, et al
   Plazomicin in multidrug-resistant complicated urinary tract infections: a scoping review.
   Ther Adv Infect Dis. 2025;12:20499361251401104.
   Abstract
   
   
8. SINGH B, Patel A, Agrawal RP, Jain SK, et al
   Trends in antibiotics resistance for urinary tract infections - A five-year retrospective study in India.
   Bioinformation. 2025;21:3010-3013.
   Abstract
   
   
9. DRAKUL D, Joksimovic B, Pejcic AV, Zivkovic-Zaric R, et al
   Rising Prevalence of Multidrug-Resistant Klebsiella spp. in Urinary Tract Infections: A Study from Doboj Hospital.
   Antibiotics (Basel). 2025;14:1234.
   Abstract
   
   
10. BENEA A, Stelea L, Turaiche M, Bogdan I, et al
    REACT-UTI: A 72-Hour Composite to Predict Early Non-Response and Length of Stay in Hospitalized Adults with Lower Urinary Tract Infection-A Prospective Observational Study.
    Biomedicines. 2025;13:2870.
    Abstract
    
    
11. SINGH P, Ahmed MN, Thakur AK, Srivastava AK, et al
    Epidemiological and antimicrobial resistance profile of catheter-associated and non-catheter urinary tract infections in trauma patients (2017-2024).
    BMC Infect Dis. 2025;25:1810.
    Abstract
    
    
12. RANGRAZ JEDDI F, Nabovati E, Sharif R, Sharif AS, et al
    The effects of information technology interventions for optimizing antibiotic prescribing in urinary tract infections: a systematic review.
    BMC Infect Dis. 2025;25:1752.
    Abstract
    
    
13. BROUGHTON E, Colosia A, Bektas M, Kuper K, et al
    Assessing the economic burden of complicated urinary tract infection: A systematic literature review.
    Eur J Health Econ. 2025 Dec 29. doi: 10.1007/s10198-025-01846.
    Abstract
    
    
14. WU KC, Belza B, Berry DL, Lewis FM, et al
    Digital Health Interventions for Urinary Tract Infection Prevention and Management in People Living with Dementia and Their Family Caregivers: A Scoping Review.
    Gerontologist. 2025 Dec 29:gnaf268. doi: 10.1093.
    Abstract
    
    
15. VANDERPOORTEN L, Vandevelde S, De Corte L, Holvoet J, et al
    Overview and resistance profiles of isolated pathogens in women with uncomplicated urinary tract infection in primary care.
    Acta Clin Belg. 2025 Dec 29:1-9. doi: 10.1080/17843286.2025.2596150.
    Abstract
    
    
16. GECKALAN D, Simsek OO, Cil Z
    Diagnostic Utility of High-Sensitivity C-Reactive Protein and Inflammatory Biomarkers in Pediatric Atypical Urinary Tract Infections.
    Niger J Clin Pract. 2025;28:1464-1469.
    Abstract
    
    
17. ARAYA T, Kita T, Higashi T, Hara R, et al
    Hyperammonemic Encephalopathy Caused by Obstructive Urinary Tract Infection Due to Urease-Positive Corynebacterium riegelii in an Elderly Woman: A Case Report.
    Cureus. 2025;17:e97833.
    Abstract
    
    
18. SADAKA Y, Nakajima K, Sasaki Y, Tsurugaya M, et al
    Preliminary clinical evaluation of cefmetazole dosing regimens in Japanese patients with urinary tract infections.
    J Pharm Health Care Sci. 2025 Dec 27. doi: 10.1186/s40780-025-00535.
    Abstract
    
    
19. KIBWANA UO, Manyahi J, Sabas DM, Chande R, et al
    Ciprofloxacin resistance in community and hospital-acquired urinary tract infections: a systematic review and meta-analysis from African population.
    BMC Infect Dis. 2025 Dec 28. doi: 10.1186/s12879-025-11546.
    Abstract
    
    
20. FLOREZ-NAVAS PC, Josa D, Silva-Monsalve E, Ballesteros N, et al
    Infective endocarditis caused by Escherichia coli O25b:H4-B2-ST131: A case report providing genotypic, phenotypic, and phylogenetic insights.
    J Int Med Res. 2025;53:3000605251404825.
    Abstract
    
    
21. RODER J, Wingen-Heimann SM, Seidel D, Froitzheim AC, et al
    Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective.
    Infection. 2025 Dec 26. doi: 10.1007/s15010-025-02711.
    Abstract
    
    
22. ISHAQ Z, Khalil K, Faiz F, Haider U, et al
    Genomic characterization and comparative analysis of multidrug-resistant uropathogenic Escherichia coli strain U1 from Pakistan revealed ST131 as dominant clade.
    Antonie Van Leeuwenhoek. 2025;119:22.
    Abstract
    
    
23. GAO K, Kumar V, Divinagracia G, Kirn TJ, et al
    Use of BacterioScan 216Dx to reduce antibiotic use for suspected urinary tract infection in the emergency department.
    Antimicrob Steward Healthc Epidemiol. 2025;5:e322.
    Abstract
    
    
24. MADARAS-KELLY KJ, Nakasone T, Maghari S, Taylor J, et al
    A pilot intervention to improve the management of urinary tract infections in outpatient settings.
    Antimicrob Steward Healthc Epidemiol. 2025;5:e338.
    Abstract
    
    
25. AUDENET F, Panis A, Fraisse G, Dariane C, et al
    Early Stent Removal at Bedside Decreases Urinary Tract Infection in Kidney Transplant Recipients: A Monocentric Prospective Study.
    Transpl Infect Dis. 2025 Dec 24:e70148. doi: 10.1111/tid.70148.
    Abstract
    
    
26. MAYOMBO NGOUSSOU E, Mounioko F, Mundunge M, Mabika Mabika R, et al
    Descriptive Epidemiology of Klebsiella spp. Urinary Tract Infections in Central Africa.
    Biomed Res Int. 2025;2025:9558259.
    Abstract
    
    
27. YE LZ, Sun JX, Chen J, Cen KK, et al
    Machine learning model for predicting urinary tract infection risk in febrile children under 3 years of age.
    Front Pediatr. 2025;13:1677292.
    Abstract
    
    
28. DIAO P, Zhong S, Chen D, Wang H, et al
    Construction and Evaluation of Nomogram Prediction Model for Urinary Tract Infection After Transurethral Bipolar Plasmakinetic Prostatectomy.
    Risk Manag Healthc Policy. 2025;18:3901-3910.
    Abstract
    
    
29. REED AL, Kayuni SA, Musaya J, Stothard JR, et al
    Development of a dynamical model to enhance understanding of epidemiology of schistosomiasis in school-aged-children.
    Sci Rep. 2025;15:45091.
    Abstract
    
    
30. FENG Q, He W, Xu Q, Cheng W, et al
    Analysis of risk factors for urinary tract infections caused by extended spectrum beta-Lactamases-producing Escherichia coli and establish the nomogram model.
    Urolithiasis. 2025;54:7.
    Abstract
    
    
31. VEIGAS E, Lanca Pereira J, Oliveira N, Lopes A, et al
    When the Urine Turns Purple: Not Always a Urinary Tract Infection.
    Cureus. 2025;17:e97200.
    Abstract
    
    
32. HILL JB, Simons A, Wright G, Anderson KE, et al
    Impact of recently initiated medications on the incidence of urinary tract infections in patients with type 2 diabetes: an observational case-control study.
    Ther Adv Drug Saf. 2025;16:20420986251401515.
    Abstract
    
    
33. DABABNEH A, Sanyaolu LN, Ahmed H, Alagiyawanna D, et al
    Women's experiences of the assessment and management of urinary tract infections during the COVID-19 pandemic: a qualitative analysis of free-text comments from a national survey in England.
    JAC Antimicrob Resist. 2025;7:dlaf241.
    Abstract
    
    
34. KUANG Y, Ni W, Wu J, Qin J, et al
    Boosting Array-based Diagnosis of Urinary Tract Infections via a Heterobifunctional Bridge-Driven Strategy.
    Angew Chem Int Ed Engl. 2025 Dec 21:e23348. doi: 10.1002/anie.202523348.
    Abstract
    
    
35. WANG X, Yin L, Li H, Li H, et al
    Orthogonal Biochemical Sensing for Concentration-Independent Bacterial Fingerprinting.
    Anal Chem. 2025;97:27844-27853.
    Abstract
    
    
36. LUKASIAK A, Wesolowski W, Neumann J, Lewandowska N, et al
    Groundwork for phage therapy: multi-faceted comparative analysis of lytic bacteriophages infecting uropathogenic Escherichia coli.
    Virology. 2026;615:110738.
    Abstract
    
    
37. KO CC, Chang LC, Hung KC, Lai YC, et al
    Association Between Sugammadex Use and Risk of Postoperative Urinary Complications after Metabolic and Bariatric Surgery: A Multi-Institutional Study.
    Obes Surg. 2025;35:5092-5100.
    Abstract
    
    
38. ZHANG EZ, Millot JC, Balasubramanian A, Davis L, et al
    Persistent Sex Disparities in Bladder Cancer Diagnosis, an Analysis of National Trends from 2012 to 2021.
    Urol Pract. 2025 Oct 10:101097UPJ0000000000000904.
    Abstract
    
    
39. HAMDAN D, Adcock JT
    Nontyphoidal Salmonella as a Rare Cause of UTI: A Case Report, Systematic Review, and Analysis of Surveillance Data.
    Int Urogynecol J. 2025;36:2349-2362.
    Abstract
    
    
40. MORAGAS A, Monfa R, Garcia-Sangenis A, Llor C, et al
    Accuracy of leukocyte esterase and nitrite tests for diagnosing bacteriuria in older adults: a systematic review and meta-analysis.
    Clin Microbiol Infect. 2026;32:19-29.
    Abstract
    
    
41. NIETO-VEGA FA, Rodriguez-Azor B, Martinez-Rivera V, Reina-Gonzalez AM, et al
    Primary vesicoureteral reflux presenting as hypertensive crisis and thrombotic microangiopathy.
    Hipertens Riesgo Vasc. 2025;42:302-304.
    Abstract
    
    
42. DOUGLASS KM, Laus K, DeAndrade S, Whitaker T, et al
    Evaluation of the Safety of Virtual Visits After In-Clinic Botox(R) Injection: A Quality Improvement Study.
    Int Urogynecol J. 2025;36:2427-2434.
    Abstract
    
    
43. WOLTSCHE J, Pacher-Deutsch C, Furst S, Gulden L, et al
    Microbial Dysbiosis in the Urinary Microbiome of Patients with Cirrhosis.
    Am J Gastroenterol. 2025 Jul 7. doi: 10.14309/ajg.0000000000003634.
    Abstract
    
    
44. PILLAI NR, Hulkower A, Gallagher S, Abraham C, et al
    Consultation-Liaison Case Conference: Treatment Over Objection in the General Hospital.
    J Acad Consult Liaison Psychiatry. 2025;66:546-552.
    Abstract
    
    
45. KOLANKO MA, Jackson R, Soreq E, David MC, et al
    Biomarkers.
    Alzheimers Dement. 2025;21 Suppl 2:e106435.
    Abstract
    
    
46. RUTA F, Avram C, Mardale E, Maior R, et al
    Histamine-Producing Intestinal Dysbiosis and Its Role in Lower Urinary Tract Infections and Irritable Bowel Syndrome in Young Women.
    Nutrients. 2025;18:16.
    Abstract
    
    
47. LIAO Y, Li Y, Wang X, Pu F, et al
    Comparative study between female patients with functional dyspepsia accompanied by abnormal urinalysis and those with urinary tract infections: a retrospective case-control study.
    Sci Rep. 2026 Jan 9. doi: 10.1038/s41598-026-35609.
    Abstract
    
    
48. ARAYA ORELLANA J, Basoalto Leon J, Napoletani Ramirez R, Aran-Sekul T, et al
    Identification and susceptibility profile of microorganisms isolated directly from urine in a cross-sectional study using matrix-assisted laser desorption/ionization time-of-flight and Phoenix M50.
    Medwave. 2026;26:e3049.
    Abstract
    
    
49. YANG J, Du M, Duan Z, Cai M, et al
    Epidemiological characteristics and antibiotic resistance of pathogens in urinary tract infection in Chengdu 2019-2023, China.
    BMC Microbiol. 2026 Jan 8. doi: 10.1186/s12866-026-04719.
    Abstract
    
    
50. ISMAIL ZS, Zhao T, Liang SH, Chibale K, et al
    Blujepa for the treatment of uncomplicated urinary tract infections.
    Trends Pharmacol Sci. 2026 Jan 7:S0165-6147(25)00283.
    Abstract
    
    
51. LOPEZ PEREZ E, Garcia-Astillero Vallecillo V, Gomez de Vicente JM, Bravo Marin S, et al
    MANCOIT Study: Pilot study on the prevention of recurrent postcoital urinary tract infection in women with D-mannose plus proanthocyanidins (PAC).
    Actas Urol Esp (Engl Ed). 2026 Jan 5:501911. doi: 10.1016/j.acuroe.2026.501911.
    Abstract
    
    
52. LIBO E, Weiss T, Youngster I, Adler A, et al
    Pathogen distribution and antimicrobial resistance in simple and complicated urinary tract infections in pediatric patients.
    Infection. 2026 Jan 7. doi: 10.1007/s15010-025-02704.
    Abstract
    
    
53. GAJDA M, Kapturkiewicz C, Kapusta D, Hareza D, et al
    Applying international urinary tract infection guidelines in Poland: epidemiologic insights from Southern Poland.
    Pol Arch Intern Med. 2026 Jan 7:17193. doi: 10.20452/pamw.17193.
    Abstract
    
    
54. HOSSAIN A, Hossain SA, Fatema AN, Wahab A, et al
    Retraction notice to "Age and gender-specific antibiotic resistance patterns among Bangladeshi patients with urinary tract infection caused by Escherichia coli" [Heliyon 6 (2020) e04161].
    Heliyon. 2025;11:e44254.
    Abstract
    
    
55. LU CY, Liu Q, Feng P, Liu HY, et al
    The Role of Prognostic Nutritional Index in UTI Susceptibility Among Female Type 2 Diabetic Patients.
    J Diabetes Res. 2025;2025:6890754.
    Abstract
    
    
56. XUE Z, Chen H, Qi Y, Zeng Q, et al
    Mechanistic insights into the inhibitory effect of epigallocatechin gallate on the production of virulence factors in Proteus mirabilis.
    Medicine (Baltimore). 2026;105:e46893.
    Abstract
    
    
57. CHANG Z, Chen J, Wang Z, Liang Y, et al
    Rapid and accurate preoperative diagnosis of urinary tract infections in urolithiasis patients: clinical validation of the HB&L system.
    BMC Infect Dis. 2026 Jan 6. doi: 10.1186/s12879-025-12444.
    Abstract
    
    
58. ADDO HO, Barimah AJ, Usman AS, Kuu-Arah P, et al
    Utilisation of antibiotics in the management of urinary tract infections among women of reproductive age at a district hospital in Ghana.
    Sci Rep. 2026 Jan 7. doi: 10.1038/s41598-025-33884.
    Abstract
    
    
59. HAMILTON ADK, Hornhaver J, Sparsoe LV, Sorensen MV, et al
    Oral Acid Load Lowers Bacterial Burden and Elevates Urinary Proinflammatory Response in a Mouse Model of Urinary Tract Infection.
    Acta Physiol (Oxf). 2026;242:e70149.
    Abstract
    
    
60. LI Y, Chen X, Chen D
    Nursing Management for the Prevention of Urinary Catheter-Associated Urinary Tract Infections in the Emergency Intensive Care Unit: A Retrospective Study.
    Arch Esp Urol. 2025;78:1410-1417.
    Abstract
    
    
61. ABOLANLE P, Akintelure D, Eylert M, Wijayasuriya DS, et al
    Exploring the Efficacy of Methenamine Hippurate Across Different Patient Groups With Recurrent Urinary Tract Infections: Experience From a University Teaching Hospital in South Wales, United Kingdom.
    Cureus. 2025;17:e98511.
    Abstract
    
    
62. CHAMODINI K, Samarasingha S, Didulanga K, Jayasekara C, et al
    Bioactive Compounds in Natural Remedies and Functional Foods for Managing Recurrent Urinary Tract Infections in Postmenopausal Women.
    J Menopausal Med. 2025;31:145-157.
    Abstract
    
    
63. BITSORI M, Poulaki RI, Galanakis E
    Diagnosis of urinary tract infections in the pediatric population - current practices, advances and progress.
    Expert Rev Anti Infect Ther. 2026 Jan 5:1-14. doi: 10.1080/14787210.2025.2611304
    Abstract
    
    
64. DUFF P
    Infection after cesarean delivery: diagnosis, pathophysiology, management, and prevention.
    Am J Obstet Gynecol. 2026;233.
    Abstract
    
    
65. FERNANDEZ-RUIZ M, San-Juan R, Montero MM, Pano-Pardo JR, et al
    How can we optimize the diagnostic and therapeutic approach of urinary tract infection? Expert opinion-based recommendations.
    Enferm Infecc Microbiol Clin (Engl Ed). 2026 Jan 2:503027.
    Abstract
    
    
66. POLYZOU E, Tsoupra S, Gavatha M, Skintzi K, et al
    Bacteremic versus Non-Bacteremic Urinary Tract Infections: Predictors of Poor Clinical Outcome.
    Rom J Intern Med. 2026 Jan 3. doi: 10.2478/rjim-2025-0025.
    Abstract
    
    
67. SINGLEY CM, Kurumaddali A, Hoover JL
    Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model.
    Antimicrob Agents Chemother. 2026;70:e0117625.
    Abstract
    
    
68. BELLANKIMATH AB, Branders S, Kegel I, Ali J, et al
    Metagenomic sequencing enables accurate pathogen and antimicrobial susceptibility profiling in complicated UTIs in approximately four hours.
    Nat Commun. 2025;17:187.
    Abstract
    
    
69. CICEK M, Tufekci B, Fehruzlu E, Kose M, et al
    Annual changes of antimicrobial resistance and antibiotic preference in urology inpatient group; a tertiary hospital experience.
    BMC Urol. 2025;26:3.
    Abstract
    
    
70. CHAKULYA M, Chisompola D, Chawela N, Hatwiko H, et al
    Prevalence and associated factors of schistosomiasis among children and adolescents visiting Chitokoloki Mission Hospital of Zambezi District.
    BMC Infect Dis. 2025;26:11.
    Abstract
    
    
71. BONTEMPS-GALLO S
    The cost of chronicity: Pseudomonas aeruginosa's silent evolution in the urinary tract.
    Microbiol Spectr. 2026;14:e0338125.
    Abstract
    
    
72. SUGIYAMA Y, Nakamura A, Ohta H, Fujita T, et al
    PstSCAB and SapBCDF are putrescine exporters in Proteus mirabilis.
    Microbiol Spectr. 2026;14:e0430623.
    Abstract
    
    
73. RAUSCHE P, Kutz JM, Rakotomalala Z, Randrianasolo BS, et al
    Evaluation of Midwife-Led Colposcopy for Female Genital Schistosomiasis Screening at Primary Level of Care in Rural Madagascar: A Cross-Sectional Study.
    Trop Med Int Health. 2025 Oct 30. doi: 10.1111/tmi.70049.
    Abstract
    
    
74. OZAY Y, Sever M, Yesilaras M, Unal A, et al
    The usefulness of previous urine culture and antibiogram results in guiding empiric antibiotic selection in the emergency department.
    Ir J Med Sci. 2025;194:2475-2483.
    Abstract
    
    
75. ALREDHA RDA, Haddawi KH, Alzerfi HSR
    Beyond the bladder: Escherichia coli UTIs drive systemic inflammation and RANKL-mediated bone resorption.
    Ir J Med Sci. 2025;194:2319-2327.
    Abstract
    
    
76. UNHAPIPATPONG C, Wang C, Schwenger KJP, Zirabamuzaale J, et al
    Association between mixed oil lipid emulsions and all-cause infections relative to soybean oil lipid emulsions in hospitalized adults: A retrospective cohort study.
    JPEN J Parenter Enteral Nutr. 2026;50:78-87.
    Abstract
    
    
77. PRAKASH A, Besra SK, Ansari MH, Ali M, et al
    A Prospective Analysis of Neurosurgery Intensive Care Unit Infections - A Tertiary Center Study.
    Ann Afr Med. 2026;25:34-37.
    Abstract
    
    
78. WIDHE E, Hambraeus M, Hedstrom E, Borjesson A, et al
    Low Risk for Urinary Tract Infection After Voiding Cystography in Children Without Dilated Vesikoureteral Reflux.
    Acta Paediatr. 2025 Dec 29. doi: 10.1111/apa.70437.
    Abstract
    
    
79. TRAUTNER BW, Cortes-Penfield NW, Gupta K, Hirsch EB, et al
    Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Introduction and Methods.
    Clin Infect Dis. 2025 Dec 30:ciaf459. doi: 10.1093.
    Abstract
    
    
80. TANDE AJ, Stevens RW, Ilges D, Lahr BD, et al
    Cumulative Antibiotic Exposure Is Associated With Ceftriaxone Resistance Among Patients With Urinary Source Gram-negative Bloodstream Infection: A Retrospective Cohort Study.
    Clin Infect Dis. 2025;81:871-878.
    Abstract
    
    
81. SHEETS AJ, Dennison J, Pogue JM, Kaye KS, et al
    Early symptom response in patients with uncomplicated urinary tract infection treated with gepotidacin or nitrofurantoin: pooled analysis from two pivotal Phase 3 studies.
    Clin Infect Dis. 2026 Jan 6:ciaf722. doi: 10.1093.
    Abstract
    
    
82. KUNWAR D, Zahavi I, Olchowski J, Dallasheh H, et al
    Antibiotic class comparisons for the treatment of pyelonephritis and complicated urinary tract infections: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2025 Dec 22:107696.
    Abstract
    
    
83. MANTZOURANI E, Ahmed H, Evans A, Macdonald S, et al
    A national pilot community pharmacy-led urinary tract infection service: clinical and patient-reported outcomes from 9077 consultations.
    J Antimicrob Chemother. 2025 Dec 24:dkaf466. doi: 10.1093.
    Abstract
    
    
84. SHUKLA AR, Srinivasan AK, Mittal S, Abdulfattah S, et al
    Reply: A Risk Stratification Model to Predict Febrile Urinary Tract Infection After Cessation of Continuous Antibiotic Prophylaxis in Children With Known Vesicoureteral Reflux.
    J Urol. 2025 Dec 31:101097JU0000000000004908. doi: 10.1097/JU.0000000000004908.
    Abstract
    
    
85. CORONA LE
    Letter: A Risk Stratification Model to Predict Febrile Urinary Tract Infection After Cessation of Continuous Antibiotic Prophylaxis in Children With Known Vesicoureteral Reflux.
    J Urol. 2025 Dec 23:101097JU0000000000004894. doi: 10.1097/JU.0000000000004894.
    Abstract
    
    
86. TZVI-BEHR S, Frishberg Y, Cytter-Kuint R, Chertin B, et al
    Emphysematous pyelonephritis and infection-related calculi.
    Pediatr Nephrol. 2026;41:361-363.
    Abstract
    
    
87. KRAUSE A, Zane GK, Rivas-Nieto AC, Mulugeta A, et al
    Assessing the relationship between menstrual products and reproductive and urogenital tract infections (RUTIs): A systematic review evaluating the evidence and recommendations for future research.
    PLoS One. 2025;20:e0332006.
    Abstract
    
    
88. ASHONG Y, Aboagye FT, Owusu-Frimpong I, Nyarko S, et al
    Prevalence of Schistosoma bovis and Schistosoma haematobium hybrids in endemic communities in Ghana.
    PLoS One. 2026;21:e0339722.
    Abstract